CagriSema Combination Dosing When combined with semaglutide, cagrilintide is administered as a fixed-ratio combination [7] : CagriSema 2.4 mg/2.4 mg Cagrilintide: 2.4 mg Semaglutide: 2.4 mg Administered as single weekly injection Separate titration of each component during escalation phase [7] Combination Benefits Single injection improves convenience Fixed ratio ensures consistent synergy Combined titration minimizes side effects 15.6% mean weight loss at 32 weeks [7] Reconstitution and Storage Handling Guidelines for Research Applications Reconstitution Use bacteriostatic water (0.9% benzyl alcohol) for multi-dose vials Sterile water for single-use applications Add solvent slowly down vial wall Gently swirl (do not shake) to dissolve Typical concentration: 1-5 mg/mL Storage Lyophilized powder: Store at -20C, protected from light Reconstituted solution: 2-8C (refrigerate) for up to 28 days with bacteriostatic water Avoid: Freezing reconstituted solution Stability: Peptide is sensitive to heat and light Administration Route and Pharmacokinetics Route: Subcutaneous injection (clinical trials used abdomen, thigh, or upper arm) [2] Absorption: Gradual absorption from subcutaneous depot

Diabetes 48:377382 Segev Y, Landau D, Marbach M, Shehadeh N, Flyvbjerg A, Phillip M (1997) Renal hypertrophy in hyperglycemic nonobese diabetic mice is associated with persistent renal accumulation of insulin-like growth factor I
The animals lost body weight and fat mass, had smaller adipocytes, and showed lower cholesterol, and notably did it with no change in food intake
Patients should be educated on the importance of monitoring and interpreting their blood sugar readings, especially before driving, operating machinery, or engaging in other activities where dizziness could pose a safety risk